Ritter Reaction Mediated by Bismuth(III) Salts: One-Step Conversion of ­Epoxides into vic-Acylamino-Hydroxy Compounds

Abstract

Bismuth salts promote a new one-step conversion of epoxides into vic-acylamino-hydroxy compounds in very high yields.

bismuth salts - epoxides - steroids - ring opening - vic-acylamino-hydroxy compounds

References and Notes

1 Ritter JJ. Minieri PP. J. Am. Chem. Soc.  1948,  70:  4045 

2a Zil’Berman EN. Russ. Chem. Rev.  1960,  29:  331 

2b Krimen LI. Cota DJ. Org. React.  1969,  17:  213 

3 Ritter JJ. Kalish J. J. Am. Chem. Soc.  1948,  70:  4048 

4 Benson FR. Ritter JJ. J. Am. Chem. Soc.  1949,  71:  4128 

5a Hathaway BA. J. Chem. Educ.  1989,  66:  776 

5b Colombo MI. Bohn ML. Rúveda EA. J. Chem. Educ.  2002,  79:  484 

6 Smith JRL. Norman ROC. Stillings MR. J. Chem. Soc., Perkin Trans. 1  1975,  1200 

7 Ducker JW. Lazer SC. Aust. J. Chem.  1970,  23:  2535 

8 Teutsch G. Shapiro EL. Herzog HL. J. Med. Chem.  1970,  13:  750 

9 Bourgery G. Frankel JJ. Julia S. Ryan RJ. Tetrahedron  1972,  28:  1377 

10 Ryan RJ. Julia S. Tetrahedron  1973,  29:  3649 

11 Narayanan CR. Kulkarni AK. Landage AB. Wadia MS. Indian J. Chem.  1974,  12:  992 

12 Narayanan CR. Kulkarni AK. Landge AB. Wadia MS. Synthesis  1977,  35 

13a Sun H. Li H. Sadler PJ. Chem. Ber. Recl.  1997,  130:  669 

13b Briand GG. Burford N. Chem. Rev.  1999,  99:  2601 

14 Tiekink ERT. Crit. Rev. Oncol./Hematol.  2002,  42:  217 

15a Freedman LD. Doak GO. Chem. Rev.  1982,  82:  15 

15b Postel M. Dunãch E. Coord. Chem. Rev.  1996,  155:  127 

15c Suzuki H. Ikegami T. Matano Y. Synthesis  1997,  249 

15d Marshall JA. Chemtracts Org. Chem.  1997,  1064 

15e Le Roux C. Dubac J. Synlett  2002,  181 

15f Leonard NM. Wieland LC. Mohan RS. Tetrahedron  2002,  58:  8373 

15g Gaspard-Iloughmane H. Le Roux C. Eur. J. Org. Chem.  2004,  2517 

15h Mulamoottil VA. Synlett  2005,  2699 

16 Salvador JAR. Silvestre SM. Tetrahedron Lett.  2005,  46:  2581 

17 Yarovaya OI. Korchagina DV. Rybalova TV. Gatilov YV. Polovinka MP. Barkhash VA. Russ. J. Org. Chem.  2004,  40:  1593 

18 Caputo R. Ferreri C. Noviello S. Palumbo G. Synthesis  1986,  499 

19

Selected Data.
Compound 2: ¹H NMR (300 MHz, CDCl₃): δ = 0.69 (3 H, s, 18-H₃), 1.12 (3 H, s, 19-H₃), 2.01 (3 H, s, CH₃COO), 2.02 (3 H, s, CH₃CONH), 4.02 (1 H, m, 6α-H), 5.16 (1 H, m, 3α-H), 5.60 (1 H, d, J = 9.7 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.9 (C₃), 75.5 (C₅), 169.5 (CONH), 170.5 (COO). IR (ATR): 3394, 2934, 2870, 1734, 1716, 1662, 1514, 1374, 1245, 1029 cm^-1.
Compound 4: ¹H NMR (300 MHz, CDCl₃): δ = 0.90 (3 H, s, 18-H₃), 1.16 (3 H, s, 19-H₃), 2.02 (3 H, s, CH₃COO), 2.05 (3 H, s, CH₃CONH), 4.12 (1 H, m, 6α-H), 5.16 (1 H, m, 3α-H), 5.66 (1 H, d, J = 9.7 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.6 (C₃), 75.4 (C₅), 169.6 (CONH), 170.5 (COO), 220.7 (C₁₇). IR (ATR): 3370, 2938, 2875, 1735, 1711, 1648, 1532, 1367, 1257, 1028 cm^-1.
Compound 6: ¹H NMR (300 MHz, CDCl₃): δ = 0.64 (3 H, s, 18-H₃), 1.12 (3 H, s, 19-H₃), 2.02 (3 H, s, CH₃COO), 2.02 (3 H, s, CH₃CONH), 2.12 (3 H, s, 21-H₃), 4.08 (1 H, m, 6α-H), 5.17 (1 H, m, 3α-H), 5.64 (1 H, d, J = 9.7 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.8 (C₃), 75.4 (C₅), 169.6 (CONH), 170.6 (COO), 209.6 (C₂₀). IR (ATR): 3381, 2940, 2870, 1728, 1701, 1654, 1533, 1364, 1246, 1030 cm^-1. ES-MS: m/z (%) = 434 (100) [M]⁺, 416 (37), 374 (20), 356 (30). Anal. Calcd for C₂₅H₃₉NO₅: C, 69.25; H, 9.07; N, 3.23. Found: C, 69.01; H, 9.27; N, 3.38.
Compound 8: ¹H NMR (300 MHz, CDCl₃): δ = 0.68 (3 H, s, 18-H₃), 1.11 (3 H, s, 19-H₃), 2.00 (3 H, s, CH₃CONH), 3.98-4.19 (2 H, m, 3α-H and 6α-H), 5.69 (1 H, d, J = 10.1 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 67.2 (C₃), 75.8 (C₅), 169.6 (CONH). IR (ATR): 3460, 3437, 2933, 2867, 1650, 1523, 1378, 1046 cm^-1.
Compound 10: ¹H NMR (300 MHz, CDCl₃): δ = 1.03 (3 H, s, 15-H₃), 2.00 (3 H, s, CH₃CONH), 3.29 (1 H, m, 9α-H), 4.14 (1 H, m, 2α-H), 5.54 (1 H, d, J = 9.2 Hz, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 57.7 (C₂), 74.9 (C₉), 169.8 (CONH). IR (ATR): 3480, 3306, 2942, 2864, 1623, 1557, 1462, 1447, 1376, 1047 cm^-1.
Compound 11: ¹H NMR (300 MHz, CDCl₃): δ = 0.69 (3 H, s, 18-H₃), 1.27 (3 H, s, 19-H₃), 1.97 (3 H, s, CH₃COO), 4.27 (1 H, m, 6α-H), 5.18 (1 H, m, 3α-H), 6.28 (1 H, d, J = 9.7 Hz, NH), 7.44-7.58 (3 H, m, Ar), 7.72-7.78 (2 H, m, Ar). ¹³C NMR (75.5 MHz, CDCl₃): δ = 70.7 (C₃), 166.6 (CONH), 170.6 (COO). IR (ATR): 3463, 2936, 2862, 1729, 1717, 1654, 1575, 1516, 1477, 1364, 1240, 1030 cm^-1.
Compound 13: ¹H NMR (300 MHz, CDCl₃): δ = 0.90 (3 H, s, 18-H₃), 1.35 (3 H, s, 19-H₃), 2.01 (3 H, s, CH₃COO), 2.01 (3 H, s, CH₃CONH), 4.76 (1 H, m, 6α-H), 4.84 (1 H, m, 3α-H), 5.25 (1 H, s, NH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 71.2 (C₃), 170.1 (CONH), 171.2 (COO), 221.3 (C₁₇). IR (ATR): 3451, 3407, 2941, 1735, 1721, 1658, 1507, 1375, 1239, 1026 cm^-1.
Compound 14: ¹H NMR (300 MHz, CDCl₃): δ = 0.70 (3 H, s, 18-H₃), 1.28 (3 H, s, 19-H₃), 2.04 (3 H, s, CH₃COO), 3.83 (1 H, m, 6α-H), 5.11 (1 H, m, 3α-H). ¹³C NMR (75.5 MHz, CDCl₃): δ = 64.0 (C₆), 71.1 (C₃), 76.4 (C₅), 171.0 (COO). IR (ATR): 3384, 2933, 1735, 1697, 1457, 1363, 1267, 1245, 1030, 687 cm^-1.